10X Genomics Inc (10X Genomics) develops an innovative genomics platform. The company’s product pipeline comprises the Chromium X series, chromium connect, and chromium controller. It offers services such as single-cell gene expression, single-cell immune profiling, fixed RNA profiling, single-cell multi-home ATAC + gene expression, spatial gene expression, and targeted gene expression. The company also provides Barcode technology which is compatible with Single Cell Gene Expression and Immune Profiling solutions allowing researchers to simultaneously measure multiple analytes, such as protein and RNA, within the same set of cells or tissues. The company operates in the US, North America, Europe and Asia. 10X Genomics is headquartered in Pleasanton, California, the US.
Headquarters
United States of America
Address
6230 Stoneridge Mall Road, Pleasanton, California, 94588
Website
www.10xgenomics.com
Telephone
1 925 4017300
No of Employees
1,243
Industry
Medical Equipment
Ticker Symbol & Exchange
TXG (NASD)
Revenue (2022)
$618.7M
19.8%
(2022 vs 2021)
EPS
XYZ
Net Income (2022)
XYZ
-53.7%
(2022 vs 2021)
Market Cap*
$3.7B
Net Profit Margin (2022)
XYZ
-28.2%
(2022 vs 2021)
* As of and is in US$
Products and Services
| Products | Services | Brands |
|---|---|---|
| Chromium Connect | Single Cell Gene Expression | Visium |
| Chromium X Series | Single Cell Immune Profiling | Chromium |
| Chromium Controller | Fixed RNA Profiling | |
| XYZ | ||
| XYZ | ||
| XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2024 | New Products/Services | In March, the company introduced the Xenium multi-modal cell segmentation kit and Xenium gene panel. |
| 2024 | New Products/Services | In March, the company introduced its Visium HD Spatial Gene Expression product. |
| 2024 | New Products/Services | In February, the company introduced GEM-X, the next generation single cell technology. |
Competitor Comparison
| Key Parameters | 10X Genomics Inc | Amgen Inc | Spero Therapeutics Inc | Abiant Inc | Murrieta Genomics LLC |
|---|---|---|---|---|---|
| Headquarters | United States of America | United States of America | United States of America | United States of America | United States of America |
| City | Pleasanton | Thousand Oaks | Cambridge | Grayslake | Murrieta |
| State/Province | California | California | Massachusetts | Illinois | California |
| No. of Employees | 1,243 | 26,700 | 46 | - | - |
| Entity Type | Public | Public | Public | Private | Private |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| John R. Stuelpnagel | Chairman | Executive Board | 2013 | 65 |
| Serge Saxonov | Director; Chief Executive Officer | Executive Board | 2012 | 46 |
| Benjamin J. Hindson | President; Chief Scientific Officer; Director | Executive Board | 2012 | 48 |
| Justin J. McAnear | Chief Financial Officer | Senior Management | 2018 | 47 |
| Michael Schnall-Levin | Chief Technology Officer | Senior Management | - | - |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward